This inventor holds 2 USPTO granted patents. Top assignees: Agouron Pharmaceuticals, Inc., Pfizer Corporation. Active years: 2006-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006-2008
Title: Dawn Marie Nowlin: Innovator in HIV Research
Introduction
Dawn Marie Nowlin is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of pharmaceutical research, particularly in the development of HIV-integrase inhibitors. With a total of 2 patents, her work has the potential to impact the treatment of HIV-mediated diseases.
Latest Patents
Dawn Marie Nowlin's latest patents focus on HIV-integrase inhibitors and pharmaceutical compositions. These patents describe bicyclic hydroxamate compounds represented by a specific formula. The compounds and compositions are designed to inhibit or modulate the enzyme activity of HIV Integrase, offering new methods for treating HIV-related conditions.
Career Highlights
Throughout her career, Dawn has worked with notable companies such as Agouron Pharmaceuticals and Pfizer. Her experience in these leading pharmaceutical firms has allowed her to contribute to groundbreaking research and development in the field of HIV treatment.
Collaborations
Dawn has collaborated with esteemed colleagues, including Qiyue Hu and Atsuo Kuki. These partnerships have further enhanced her research efforts and innovation in the pharmaceutical industry.
Conclusion
Dawn Marie Nowlin is a dedicated inventor whose work in HIV research is paving the way for new treatment options. Her innovative patents and collaborations highlight her commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile